Publisher
Games Published by Randumb Studios: Revenue & Sales Estimates
Est. catalog lifetime net (USD): $1.8MRevenue estimates for the 32 Steam games published by Randumb Studios, ranked by estimated net revenue. Available estimated lifetime net (USD): $1.8M.
Catalog Est. Lifetime Net (USD)
$1.8M
Estimates for 26 of 32 tracked games
Tracked games
32
Top Earner
The Test
$891.1K
Coverage: 32 tracked titles; 26 with net estimates; 6 without. 22 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.
Role: Publisher. These are lifetime estimates for games credited to Randumb Studios; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.
Recorded release dates: 2019-11-22–2026-02-09 (may include announced dates).
Largest title accounts for 49.3% of available estimated net revenue. Coverage gaps can change this share.
Showing 1–32 of the top 32 displayed entries, from 32 tracked titles. Figures include only available estimates. Search the full catalog .
Rows 1–32 · Page 1 of 1
| # | Game | Est. lifetime net (USD) | Positive reviews (raw) | Release |
|---|---|---|---|---|
| 1 |  The Test | $891.1K | 97%Positive (20.1K) | Feb 24, 2020 |
| 2 |  The Test: Hypothesis Rising | $262.6K | 98%Positive (5.9K) | Apr 27, 2020 |
| 3 |  The Test: Final Revelation | $208K | 98%Positive (5.4K) | Oct 12, 2020 |
| 4 |  The Test: Reality Check | $69.7K | 98%Positive (627) | Feb 24, 2025 |
| 5 |  The Testing Chamber | $67K | 97%Positive (688) | Mar 28, 2022 |
| 6 |  The Confession | $53.7K | 95%Positive (1K) | May 18, 2020 |
| 7 |  The Horrorscope | $48.7K | 94%Positive (1.1K) | Mar 9, 2020 |
| 8 |  The Advisor - Episode 1: Royal Pain | $41.9K | 97%Positive (602) | May 31, 2021 |
| 9 |  The Test: Reimagined | $27.4K | 88%Positive (89) | Feb 9, 2026 |
| 10 |  The Horrorscope: Fatal Awakening | $23.8K | 93%Positive (416) | Aug 24, 2020 |
| 11 |  WTF Is Wrong With You? | $17K | 93%Positive (361) | Jun 14, 2021 |
| 12 |  The Journey - Episode 1: Whatever This Is | $13.9K | 98%Positive (295) | Apr 19, 2021 |
| 13 |  Medieval Fantasy Survival Simulator | $11.6K | 97%Positive (251) | Feb 24, 2022 |
| 14 |  Survivor Dieland | $10.7K | 95%Positive (232) | Mar 1, 2021 |
| 15 |  Survive or Thrive | $9.9K | 98%Positive (236) | Sep 7, 2020 |
| 16 |  Gobby McGobblenutz Presents: The Art of the Dad Joke: Chapter 1 | $9.5K | 91%Positive (166) | Nov 15, 2021 |
| 17 | Fateweaver: The Alchemist's Quandary | $6.5K | 98%Positive (98) | Feb 27, 2023 |
| 18 |  WTF Do You Know? | $6.5K | 95%Positive (154) | May 2, 2022 |
| 19 |  Zombie Apocalypse Survival Simulator | $5.7K | 99%Positive (118) | Oct 17, 2022 |
| 20 | Fateweaver: Smash or Pass | $5.3K | 94%Positive (79) | Apr 10, 2023 |
| 21 |  Gobby McGobblenutz Presents - The Questionably Quirky Quiz Show | $4.4K | 99%Positive (142) | Oct 4, 2021 |
| 22 | The Summoning | $3.3K | 71%Positive (77) | Nov 22, 2019 |
| 23 | Medieval Fantasy Survival Simulator 2: Gladiator Edition | $3.1K | 95%Positive (73) | Nov 7, 2022 |
| 24 | The Journey - Episode 2: Words of Wisdom | $3K | 97%Positive (93) | Jun 6, 2022 |
| 25 | Naked News | $2.8K | 65%Mixed (108) | Feb 7, 2020 |
| 26 | The Twins | $1.2K | 78%Positive (46) | Jan 24, 2020 |
| 27 | Chasing Demons | — | (0) | — |
| 28 |  The Test: Secrets of the Soul | — | 98%Positive (1.5K) | Feb 20, 2023 |
| 29 |  The Test: Secrets of the Soul 2 | — | 98%Positive (676) | Apr 10, 2023 |
| 30 |  A Work of Art | — | 95%Positive (344) | Oct 14, 2024 |
| 31 | Familiar Friends: What's Your Familiar? | — | 93%Positive (181) | Nov 11, 2024 |
| 32 | Eternity | — | (0) | — |
Get real-time dashboards, historical trends, and AI-powered analysis
Explore on PlayRev(opens in new tab)Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.